Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $5.38 billion. The enterprise value is $6.23 billion.
Important Dates
The last earnings date was Monday, March 2, 2026, after market close.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 315.33 million shares outstanding. The number of shares has increased by 24.33% in one year.
| Current Share Class | 315.33M |
| Shares Outstanding | 315.33M |
| Shares Change (YoY) | +24.33% |
| Shares Change (QoQ) | +45.83% |
| Owned by Insiders (%) | 1.70% |
| Owned by Institutions (%) | 96.04% |
| Float | 234.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 124.40 |
| PS Ratio | 16.85 |
| Forward PS | 6.81 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 19.32 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15
| Current Ratio | 1.15 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.76% |
| Return on Invested Capital (ROIC) | -48.27% |
| Return on Capital Employed (ROCE) | -11.26% |
| Weighted Average Cost of Capital (WACC) | 34.64% |
| Revenue Per Employee | $981,597 |
| Profits Per Employee | -$863,815 |
| Employee Count | 325 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $583,000 in taxes.
| Income Tax | 583,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.14% in the last 52 weeks. The beta is 6.89, so Core Scientific's price volatility has been higher than the market average.
| Beta (5Y) | 6.89 |
| 52-Week Price Change | +83.14% |
| 50-Day Moving Average | 17.27 |
| 200-Day Moving Average | 16.15 |
| Relative Strength Index (RSI) | 53.27 |
| Average Volume (20 Days) | 12,500,825 |
Short Selling Information
The latest short interest is 63.10 million, so 20.01% of the outstanding shares have been sold short.
| Short Interest | 63.10M |
| Short Previous Month | 59.27M |
| Short % of Shares Out | 20.01% |
| Short % of Float | 26.96% |
| Short Ratio (days to cover) | 5.50 |
Income Statement
In the last 12 months, Core Scientific had revenue of $319.02 million and -$280.74 million in losses. Loss per share was -$0.88.
| Revenue | 319.02M |
| Gross Profit | 54.59M |
| Operating Income | -176.30M |
| Pretax Income | -288.03M |
| Net Income | -280.74M |
| EBITDA | -107.39M |
| EBIT | -176.30M |
| Loss Per Share | -$0.88 |
Full Income StatementBalance Sheet
The company has $311.38 million in cash and $1.16 billion in debt, with a net cash position of -$851.15 million or -$2.70 per share.
| Cash & Cash Equivalents | 311.38M |
| Total Debt | 1.16B |
| Net Cash | -851.15M |
| Net Cash Per Share | -$2.70 |
| Equity (Book Value) | -962.74M |
| Book Value Per Share | -3.06 |
| Working Capital | 114.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $278.25 million and capital expenditures -$729.00 million, giving a free cash flow of -$450.75 million.
| Operating Cash Flow | 278.25M |
| Capital Expenditures | -729.00M |
| Depreciation & Amortization | 68.91M |
| Net Borrowing | -37.80M |
| Free Cash Flow | -450.75M |
| FCF Per Share | -$1.43 |
Full Cash Flow StatementMargins
Gross margin is 17.11%, with operating and profit margins of -55.26% and -90.47%.
| Gross Margin | 17.11% |
| Operating Margin | -55.26% |
| Pretax Margin | -90.29% |
| Profit Margin | -90.47% |
| EBITDA Margin | -33.66% |
| EBIT Margin | -55.26% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.33% |
| Shareholder Yield | -24.33% |
| Earnings Yield | -5.22% |
| FCF Yield | -8.38% |
Analyst Forecast
The average price target for Core Scientific is $24.25, which is 42.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.25 |
| Price Target Difference | 42.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 54.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.8 |
| Piotroski F-Score | 3 |
